Compare PAYC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PAYC | RGEN |
|---|---|---|
| Founded | 1998 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6B | 6.6B |
| IPO Year | 2014 | 1995 |
| Metric | PAYC | RGEN |
|---|---|---|
| Price | $218.13 | $166.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 12 |
| Target Price | ★ $168.79 | $167.67 |
| AVG Volume (30 Days) | 890.8K | ★ 1.3M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.17% | N/A |
| EPS Growth | N/A | ★ 286.96 |
| EPS | ★ 5.43 | 0.24 |
| Revenue | ★ $433,047,000.00 | $141,236,000.00 |
| Revenue This Year | $8.79 | $14.30 |
| Revenue Next Year | $7.48 | $14.52 |
| P/E Ratio | ★ $41.25 | $698.10 |
| Revenue Growth | N/A | ★ 35.10 |
| 52 Week Low | $104.90 | $100.99 |
| 52 Week High | $234.60 | $175.77 |
| Indicator | PAYC | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 76.01 | 71.07 |
| Support Level | $114.49 | $156.65 |
| Resistance Level | N/A | $173.10 |
| Average True Range (ATR) | 8.92 | 6.99 |
| MACD | 4.32 | 1.79 |
| Stochastic Oscillator | 90.54 | 96.87 |
Paycom is a cloud-based human capital management provider offering payroll, compliance, and human resources management solutions. The firm's solutions are available on a unified, modular platform, and customers are billed for access on a subscription basis. Paycom's customer base skews toward the midmarket and is primarily based in North America. As of 2025, the firm manages records for 7.4 million employees across more than 20,000 clients on a parent-company-group basis.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.